The percentage of CD3+, CD4+ and CD8+ T lymphocytes that expressed BTLA, HVEM and LIGHT were all significantly different between controls and RA patients (all p < 0.05) (Table 2, Figs 1, 2, 3 and 4). This evidence concerns the gene BTLA and rheumatoid arthritis.